StrideLink has filed a notice of an exempt offering of securities to raise $4,315,000.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, StrideLink is raising up to $4,315,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About StrideLink
StrideLink is a healthcare technology company that provides remote patient monitoring solutions focused on gait and mobility for orthopedic care and movement disorders. Using wearable sensors and a software platform, StrideLink captures daily snapshots of a patients full gait cycle with clinical-grade accuracy, enabling detection of subtle changes that basic fitness trackers often miss. The companys system delivers real-time recovery and mobility insights across a broad spectrum of orthopedic procedures including knee, hip, spine, and foot and ankle supported by a robust and growing dataset. These objective gait metrics help clinicians benchmark recovery, track outcomes, visualize progress, and link changes in gait to adverse event detection, expected recovery timelines, functional outcomes, and underlying conditions. By replacing subjective gait assessments and traditional, bulky gait labs with simple wearable technology and an intuitive dashboard, StrideLink aims to make advanced gait analysis more accessible, efficient, and informative for both healthcare providers and patients.
To learn more, visit https://www.stridelinkinc.com/
LinkedIn: https://www.linkedin.com/company/stridelink/
Contact:
Marzeah Khorramabadi, President and Chief Executive Officer
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.
